Health-related quality of life of HIV-infected women: Evidence for the reliability, validity and responsiveness of the Medical Outcomes Study Short-Form 20

Quality of Life Research

Volumn 5, Issue 1, 1996, Pages 47-55

  Smith, M Y ^a   Feldman, J ^b   Kelly, P ^c   DeHovitz, J A ^b   Chirgwin, K ^b   Minkoff, H ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY   (United States)

Author keywords

Health related quality of life; HIV infected women; MOS SF 20

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; HEALTH SURVEY; LONGITUDINAL STUDY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; REPRODUCIBILITY; UNITED STATES;

ADULT; FEMALE; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; NEW YORK; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS;

EID: 0029877388     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00435968     Document Type: Article

References (49)

1. Centers for Disease Control. Estimates of HIV prevalence and projected AIDS cases: Summary of a workshop, October 31-November 1, 1989. Morbidity and Mortality Weekly Report Atlanta: Centers for Disease Control. 1990: February.
2. Melnick, S.L., Sherer R, Louis T.A. et al. Survival and disease progression according to gender of patients with HIV infection. J Amer Med Assoc 1994; 272(24): 1915-1921.
3. Centers for Disease Control. HIV/AIDS surveillance report (through November, 1994). Atlanta: Centers for Disease Control. 1994: December.
4. Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science 1991; 253: 37-42.
5. New York City Department of Health AIDS surveillance update: Third quarter, 1995.
6. Minkoff H, DeHovitz JA. Care of women infected with human immunodeficiency virus. J Amer Med Assoc 1991; 266: 2253-2258.
7. Carpenter CCJ, Mayer KG, Fisher A, et al. (1989) Natural history of acquired immunodeficiency syndrome in women in Rhode Island. Amer J Med 1989; 86: 771-776.
8. Carpenter CCJ, Mayor KH, Stein MD, et al. Human immuodeficiency virus infection in North American women: experience with 200 cases and a review of the literature. Med 1991; 70: 307-325.
9. Friedland GH, Saltsman B, Vileno J, Freeman, K, Schrager LK, Klein RS. Survival differences in patients with AIDS. J Acq Imm Def Sym 1991; 4: 144-153.
10. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human immunodeficiency infection. Ann Int Med 1992; 116: 129-137.
11. Kaplan RM, Anderson JP, Wu AW, Matthews WC, Kozin F, Orenstein D. The Quality of Well-Being Scale: Applications in AIDS, cystic fibrosis, and arthritis. Med Care 1989; 27(3): S27-S43.
12. Wu AW, Matthews WC, Brysk LT, et al. (1990) Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. J Acq Imm Def Sym 1990; 3: 683-6xx.
13. Wu AW, Rubin HR, Matthews WC, et al., A health status questionnaire using 30 items from the Medical Outcomes Study: Preliminary validation in persons with early HIV infection. Med Care 1991; 29(8): 786-798.
14. Lubeck D, Fries J. Quality of life among persons with HIV infection. In: Proceedings of VIII International Conference on AIDS. Amsterdam: #PoB3568. 1992.
15. Ganz PA, Coscarelli Schag CA, Kahn B, Petersen L, Hirji K. Describing the health-related quality of life impact of HIV infection: Findings from a study using the HIV Overview of Problems-Evaluation System (HOPES). Qual Life Res 1993; 2: 109-119.
16. Revicki D, Wu AW, Murray MI. Change in clinical status, health status and health utility outcomes in HIV-infected patients. Med Care 1995; 33(4): AS173-AS182.
17. Burgess A, Catalan J, Deyer M, et al. The reliability and validity of two HIV-specific health-related quality of life measures. AIDS 1993; 7: 1001-1009.
18. Lubeck DF, Fries JP. Health status among persons infected with human immunodeficiency virus: A community-based study. Med Care 1993; 31: 269-276.
19. Hays RD, Shapiro MF. An overview of generic health related quality of life measures for HIV research. Qual Life Res 1992; 1: 91-101.
20. Cunningham WE, Bozzette SA, Hays RD, Kanouse DE, Shapiro MF. Comparison of health-related quality of life in a clinical trial and nonclinicial trial human immunodeficiency virus-infected cohort. Med Care 1995; 33: AS15-AS25.
21. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988; 26: 724-735.
22. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbidity and Mortality Weekly Report 1987; 36: 3S-15S.
23. Schag CC, Heinrich RL, Ganz PA. Karnofsky Performance Status Revisited: Reliability, Validity and Guidelines. J Clinical Oncology 1984; 2(3): 187-193.
24. National Institute of Allergy and Infectious Disease: AIDS Clinical Trials Group, Protocol ACTC, 241. pg 18.
25. Fishl MA, Richman DD, Greico MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. New Eng J Med 1987; 317: 185-191.
26. Connolly KJ, Allan JD, Fitch H, et al. Phase 1 study of 2′, 3′ dideoxysine administered orally twice daily to patients with AIDS or AIDS-related complex and hemotologic intolerance to zidovudine. Amer J Med 1991; 91: 471-478.
27. Fischl MA, Olson RM, Follansbee SE et al. Zalcitabine compared with zidovudine in patients with advanced HTV-1 infection who received previous zidovudine therapy. Ann Int Med 1993; 118: 762-769.
28. Little J. AIDS home health care, attendant and hospice care pilot project. Los Angeles: California Department of Health Services, 1988: 53.
29. Wu AW, Rubin HR. Measuring health status and quality of life in HIV and AIDS. Psych Health 1992; 6: 251-264.
30. Schag CC, Heinrich RL, Ganz PA. Karnofsky Performance Status revisited: reliability, validity and guidelines. J Clin Oncol 1984; 2: 187-193.
31. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status: An examination of its reliability and validity in a research setting. Cancer 1984; 53: 2202-2207.
32. Grieco A, Long CJ. Investigation of the Karnofsky Performance Status as a measure of quality of life. Health Psych 1984; 3: 129-142.
33. McDowell I, Newell C, eds. Measuring health: A guide to rating scales and questionnaires. New York: Oxford University Press, 1987.
34. Stewart A., Hays RD, Ware JE. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988; 26: 786-798.
35. Stewart AL, Hays RD, Ware JE. Methods of validating MOS health measures. In: Measuring functioning and well-being: The Medical Outcomes Study approach. Durham: Duke University Press. 1992.
36. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989; 27(3): S178-S189.
37. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
38. Verbrugge L. Gender and health: An update on hypotheses and evidence. J Health Soc Beh 1985; 26: 156-182.
39. Verbrugge L. The twain meet: Empirical explanations of sex differences in health and mortality. J Health Soc Beh 1989; 30: 282-304.
40. Stowe A, Ross MW, Wodak A, Thomas GV, Larson SA. Significant relationships and social supports of injecting drug users and their implications for HIV/AIDS services. AIDS Care 1993; 5(1): 23-33.
41. Stein M, Piette J, Mor V, et al. Differences in access to azidothymidine (AZT) among symptomatic HIV-infected persons. J Gen Int Med 1991; 6: 35-40.
42. Roche A, Guray C, Saunders J. General practitioners' experiences of patients with drug and alcohol problems. Brit J Addic 1991; 86: 263-275.
43. Wu AW, Rubin HR, Matthews WC, et al. Functional status and well-being in a placebo-controlled trial of zidovudine in early AIDS-related complex. J Acq Imm Def Sym 1993; 6: 452-460.
44. Breitbart W, Passik S, Bronough T, et al. Pain in the ambulatory AIDS patient: prevalence and psychosocial correlates (abstract). 38th Annual Meeting, Academy of Psychosomatic Medicine, October 17-20, Atlanta, Georgia. 1991.
45. Breitbart W, Passik S, Rosenfeld B, McDonald M, Thaler H, Portenoy R. Undertreatment of pain in AIDS (abstract). 13th Annual Meeting, American Pain Society, November 10-13, Miami, Florida. 1994: 17-20.
46. Smith MY, Rapkin BD. Social support and barriers to family involvement in caregiving for persons with AIDS: Implications for patient education. Patient Edu Coun (in press).
47. Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 1993; 2: 441-449.
48. MacKenzie CR, Charlson ME, DiGoia D, et al. Can the Sickness Impact Profile measure change? An example of scale assessment. J Chronic Disease 1986; 39: 429-438.
49. Chambers LW, Haight M, Norman G, et al. Sensitivity to change and the effect of mode of administration on health status measurement. Med Care 1987; 25: 470-480.